Lipoprotein(a): the perpetual supporting actor
Open Access
- 14 July 2018
- journal article
- editorial
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 39 (27), 2597-2599
- https://doi.org/10.1093/eurheartj/ehy385
Abstract
This editorial refers to ‘Cardiovascular disease risk associated with elevated lipoprotein(a) attenuates at low low-density lipoprotein cholesterol levels in a primary prevention setting’†, by R. Verbeek et al., on page 2589.Keywords
Funding Information
- Swiss National Science Foundation (SPUM 33CM30-124112, SPUM 33CM30-140 336)
- Geneva University Hospitals
- Swiss Heart Foundation
- de Reuter Foundation
- Gerbex-Bourget Foundation
- Gustave-Prevot and Schmidheiny Foundation
This publication has 18 references indexed in Scilit:
- Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in HumansCirculation, 2016
- Structure, function, and genetics of lipoprotein (a)Journal of Lipid Research, 2016
- PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the LDL receptor's roleJournal of Lipid Research, 2016
- High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort studyThe Lancet Diabetes & Endocrinology, 2016
- Lipoprotein(a) Interactions With Low‐Density Lipoprotein Cholesterol and Other Cardiovascular Risk Factors in Premature Acute Coronary Syndrome (ACS)Journal of the American Heart Association, 2016
- Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 studyThe Lancet, 2015
- Lipoprotein(a) for Risk Assessment in Patients With Established Coronary Artery DiseaseJournal of the American College of Cardiology, 2013
- Lipoprotein(a) as a cardiovascular risk factor: current statusEuropean Heart Journal, 2010
- Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular MortalityJama-Journal Of The American Medical Association, 2009
- Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial InfarctionJama-Journal Of The American Medical Association, 2009